Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Novo Nordisk eyes drug development program
Mass Device
Tue, 10/4/16 - 10:15 am
Tags:
Novo Nordisk, diabetes, drug development
Why Novo Nordisk Expects Double-Digit Growth in Diabetes Care in 2016
Market Realist
Fri, 09/30/16 - 01:06 pm
Tags:
Novo Nordisk, diabetes
U.S. payer pressures force Novo Nordisk to cut loose 1,000 staffers
Fierce Pharma
Thu, 09/29/16 - 08:25 am
Tags:
Novo Nordisk, layoffs, R&D
Which drugmakers have the healthiest presence on social media?
Medical Marketing and Media
Wed, 09/28/16 - 10:40 am
Tags:
social media, Eli Lilly, JNJ, Boehringer Ingelheim, Novo Nordisk
Novo Shows Its Devotion To Tresiba's Cause
Seeking Alpha
Wed, 09/28/16 - 10:20 am
Tags:
Novo Nordisk, diabetes, insulin, Tresiba
Novo Nordisk's diabetes drug semaglutide cuts heart risk by 26 percent
Yahoo/Reuters
Sat, 09/17/16 - 01:16 pm
Tags:
Novo Nordisk, semaglutide, diabetes
Novo pulls 71,000 kits of glucagon med from US market
BioPharma Dive
Thu, 09/15/16 - 07:20 pm
Tags:
Novo Nordisk, recalls, glucagon, GlucaGen HypoKit, diabetes
Novo Nordisk faces delay for insulin combo
BioPharma Dive
Tue, 09/6/16 - 11:03 am
Tags:
Novo Nordisk, diabetes, insulin, IDegLira
Departing Pharma CEOs Leave Waning Sales for Successors to Solve
Bloomberg
Fri, 09/2/16 - 11:27 am
Tags:
Pharma CEOs, Novo Nordisk, Lars Sorenson, Gilead Sciences, John Martin, Eli Lilly, John Lechleiter, GSK, Andrew Witty
Novo Nordisk chief Lars Rebien Sorensen to step down early as pricing pressures mount
Fierce Pharma
Thu, 09/1/16 - 09:20 am
Tags:
Novo Nordisk, Lars Sorenson
Novo Nordisk Vs. Oramed - A Second Look At The Battle For Oral Insulin
Seeking Alpha
Mon, 08/22/16 - 10:10 pm
Tags:
Novo Nordisk, Oramed, insulin, oral insulin, diabetes, NN1953, ORMD-0801
Sanofi can’t even buy a break now, as rival Novo speeds ahead on diabetes showdown
Endpoints
Mon, 08/22/16 - 11:41 am
Tags:
Sanofi, Novo Nordisk, diabetes, Lantus, Xultophy
The ‘don’t eat me’ antidote: GlaxoSmithKline, Roche and Novo back $86M startup in high-stakes CD47 showdown
Endpoints
Tue, 08/16/16 - 11:16 am
Tags:
GSK, Roche, Novo Nordisk, Tioma Therapeutics, CD47, immuno-oncology
Novo Nordisk sees pricing challenges "intensifying"
BioPharma Dive
Tue, 08/9/16 - 10:47 pm
Tags:
Novo Nordisk, drug pricing
Novo's insulin pill shows promise in mid-stage trial
Yahoo/Reuters
Fri, 08/5/16 - 11:32 am
Tags:
Novo Nordisk, clinical trials, diabetes, insulin, OI338GT
Novo’s Victoza Diabetes Medicine Rebuffed by Express Scripts
Bloomberg
Tue, 08/2/16 - 08:50 am
Tags:
Novo Nordisk, Express Scripts, Victoza, PBMs, diabetes
Diabetes sales rocket toward $60B, with Novo and Lilly's GLP-1s first in line for growth
Fierce Pharma
Mon, 07/11/16 - 09:15 am
Tags:
diabetes, Novo Nordisk, Eli Lilly, GLP-1 agonist, Victoza, Trulicity
The World's 12 Most Reputable Pharmaceutical Companies In 2016
Forbes
Sat, 07/2/16 - 12:28 pm
Tags:
Bayer, Abbott Labs, Novo Nordisk, Roche, Merck
Could Novo Nordisk’s 2016 Earnings Impress Wall Street?
Marketwatch
Tue, 06/28/16 - 11:06 am
Tags:
Novo Nordisk, earnings
How Big Is the Diabetes Treatment Market?
Motley Fool
Wed, 06/22/16 - 07:06 pm
Tags:
diabetes, Eli Lilly, Novo Nordisk

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.